irinotecan

You have access
Chemoembolization in Colorectal Liver Metastases: The Rebirth
GIAMMARIA FIORENTINI, CAMILLO ALIBERTI, LUCA MULAZZANI, PAOLO COSCHIERA, VINCENZO CATALANO, DAVID ROSSI, PAOLO GIORDANI and STEFANO RICCI

Anticancer Research February 2014, 34 (2) 575-584;
You have access
Genetically-engineered Human Neural Stem Cells with Rabbit Carboxyl Esterase Can Target CNS Lymphoma
WONYOUNG KANG, JUYOUN JIN, HEEKYOUNG YANG, HO JUN SEOL, KANG HO KIM, JUNG-II LEE, SEUNG U. KIM, KYEUNG MIN JOO and DO-HYUN NAM

Anticancer Research December 2013, 33 (12) 5335-5342;
You have access
Non-randomized Comparison Between Irinotecan plus Mitomycin C and Irinotecan Alone in Patients with Advanced Gastric Cancer Refractory to Fluoropyrimidine and Platinum
AKIRA UEDA, AYUMU HOSOKAWA, KOHEI OGAWA, HIROKI YOSHITA, HIROSHI MIHARA, TAKAYUKI ANDO, SHINYA KAJIURA, HARUKA FUJINAMI, JUN NISHIKAWA, MASAMI MINEMURA, MITSUHIRO TERADA, TAKASHI KOBAYASHI, NAOKI HORIKAWA, KAZUHISA YABUSHITA, MASAYUKI NOTE and TOSHIRO SUGIYAMA

Anticancer Research November 2013, 33 (11) 5107-5111;
You have access
Pharmacokinetic Assessment of Irinotecan, SN-38, and SN-38-Glucuronide: A Substudy of the FIRIS Study
TAROH SATOH, HIROFUMI YASUI, KEI MURO, YOSHITO KOMATSU, SHINICHI SAMESHIMA, KENSEI YAMAGUCHI and KENICHI SUGIHARA

Anticancer Research September 2013, 33 (9) 3845-3853;
You have access
Etoposide Improves Survival in High-grade Glioma: A Meta-Analysis
ALEXIS LEONARD and JOHANNES E. WOLFF

Anticancer Research August 2013, 33 (8) 3307-3315;
You have access
Efficacy of Postoperative Oxaliplatin- or Irinotecan-based Chemotherapy After Curative Resection of Synchronous Liver Metastases from Colorectal Cancer
HUNG-CHIH HSU, WEN-CHI CHOU, WEN-CHI SHEN, CHIAO-EN WU, JEN-SHI CHEN, CHI-TING LIAU, YUNG-CHANG LIN and TSAI-SHENG YANG

Anticancer Research August 2013, 33 (8) 3317-3325;
You have access
UDP-glucuronosyltransferase (UGT) 1A1*28 Polymorphism-directed Phase II Study of Irinotecan with 5’-deoxy-5-fluorouridine (5’-DFUR) for Metastatic Colorectal Cancer
SHINSUKE KANEKIYO, SHOICHI HAZAMA, HIROSHI KONDO, ATSUSHI NAGASHIMA, RYUICHI ETO, SHIN YOSHIDA, RYOICHI SHIMIZU, ATSUHIRO ARAKI, TATSUHITO YAMAMOTO, TETSUJI UCHIYAMA, SHIGEFUMI YOSHINO, NAOKO OKAYAMA, YUJI HINODA and MASAAKI OKA

Anticancer Research August 2013, 33 (8) 3423-3430;
You have access
A Pilot Study of Salvage Irinotecan Monotherapy for Advanced Biliary Tract Cancer
TAKASHI SASAKI, HIROYUKI ISAYAMA, YOUSUKE NAKAI, NAMINATSU TAKAHARA, YUMIKO SATOH, DAIYA TAKAI, HIROFUMI KOGURE, NATSUYO YAMAMOTO, KENJI HIRANO, MINORU TADA, YUTAKA YATOMI and KAZUHIKO KOIKE

Anticancer Research June 2013, 33 (6) 2619-2622;
You have access
ABCG2 Inhibitor YHO-13351 Sensitizes Cancer Stem/Initiating-like Side Population Cells to Irinotecan
YOSHIYUKI SHISHIDO, SATOSHI UENO, RYUTA YAMAZAKI, MASATO NAGAOKA and TAKESHI MATSUZAKI

Anticancer Research April 2013, 33 (4) 1379-1386;
You have access
High-dose FOLFIRI, Surgery, and Radiofrequency Ablation for Patients with Unresectable Liver Metastases from Colorectal Cancer
MOHAMED HEBBAR, STÉPHANIE TRUANT, CHRISTOPHE DESAUW, GERALDINE SERGENT-BAUDSON, STEPHANE CATTAN, GUILLAUME PIESSEN and FRANÇOIS-RENE PRUVOT

Anticancer Research April 2013, 33 (4) 1603-1607;

Main menu

User menu

Search

irinotecan

Pages